Vittal Vasista
2016
In 2016, Vittal Vasista earned a total compensation of $1.1M as Chief Financial Officer at Regenxbio.
Compensation breakdown
| Non-Equity Incentive Plan | $104,125 |
|---|---|
| Option Awards | $659,804 |
| Salary | $349,925 |
| Other | $16,184 |
| Total | $1,130,038 |
Vasista received $659.8K in option awards, accounting for 58% of the total pay in 2016.
Vasista also received $104.1K in non-equity incentive plan, $349.9K in salary and $16.2K in other compensation.
Rankings
In 2016, Vittal Vasista's compensation ranked 7,650th out of 14,075 executives tracked by ExecPay. In other words, Vasista earned more than 45.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,650 out of 14,075 | 46th |
Division Manufacturing | 2,900 out of 5,486 | 47th |
Major group Chemicals And Allied Products | 956 out of 1,900 | 50th |
Industry group Drugs | 741 out of 1,543 | 52nd |
Industry Biological Products, Except Diagnostic Substances | 131 out of 287 | 54th |
Source: SEC filing on April 11, 2019.
Vasista's colleagues
We found three more compensation records of executives who worked with Vittal Vasista at Regenxbio in 2016.